Pathology of polyps detected in the bowel cancer screening programme

Diagnostic Histopathology

Volumn 17, Issue 11, 2011, Pages 495-504

  Foss, Fiona A ^a   West, Kevin P ^b   McGregor, Angus H ^b  

^a NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^b LEICESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

Adenocarcinoma; Adenoma; Colorectal; Histopathology; NHS Bowel Cancer Screening Programme; Polyp; Precursor lesions

Indexed keywords

ARTICLE; CANCER SCREENING; COLON ADENOCARCINOMA; COLON ADENOMA; COLON POLYP; DIFFERENTIAL DIAGNOSIS; DYSPLASIA; HISTOPATHOLOGY; HUMAN; VILLOUS ADENOMA;

EID: 82455212270     PISSN: 17562317     EISSN: 18767621     Source Type: Journal    
DOI: 10.1016/j.mpdhp.2011.08.002     Document Type: Article

References (55)

1. NHS Bowel Cancer Screening Programme 2010, http://www.cancerscreening.nhs.uk/bowel/index.html.
2. Correa P. Epidemiology of polyps and cancer in the human intestine. Gastroenterology 1979, 77:1245-1251.
3. Williams A.R., Balasooriya B.A., Day D.W. Polyps and cancer of the large bowel: a necroscopy study in Liverpool. Gut 1982, 23:835-842.
4. UK Colorectal Cancer Screening Pilot Team. Evaluation of the UK Colorectal Cancer Screening Pilot. Final report 2003, http://www.cancerscreening.nhs.uk/bowel/pilotevaluation.html.
5. Towler B., Irwig L., Glasziou P., et al. A systematic review of the effects of screening for colorectal cancer using the faecal occult blood test, Hemoccult. Br Med J 1998, 317:559-565.
6. Hardcastle J.D., Chamberlain J.O., Robinson M.H.E., et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996, 348:1472-1477.
7. Weller D., Moss S., Butler P., et al. English Pilot of Bowel Cancer Screening: an evaluation of the second round. Final Report to the Department of Health February 2006, Revised August 2006. http://www.cancerscreening.nhs.uk/bowel/index.html.
8. Yoon H., Martin A., Benamouzig R., et al. Inter-observer agreement on histological diagnosis of colorectal polyps: the APACC study. Gastroenterol Clin Biol 2002, 26:220-224.
9. Cross S., Betmouni S., Burton J., et al. What levels of agreement can be expected between histopathologists assigning cases to discrete nominal categories? A study of the diagnosis of hyperplastic and adenomatous colorectal polyps. Mod Pathol 2000, 13:941-944.
10. Jensen P., Krogsgaard M., Christiansen J., et al. Observer variability in the assessment of type and dysplasia of colorectal adenomas, analyzed using kappa statistics. Dis Colon Rectum 1995, 38:195-198.
11. Brown L.J., Smeeton N.C., Dixon M.F. Assessment of dysplasia in colorectal adenomas: an observer variation and morphometric study. J Clin Pathol 1985, 38:174-179.
12. Silcocks P.B. Measuring repeatability and validity of histological diagnosis - a brief review with some practical examples. J Clin Pathol 1983, 36:1269-1275.
13. Denis B., Peters C., Chapelain C., et al. Diagnostic accuracy of community pathologists in the interpretation of colorectal polyps. Eur J Gastroent Hepatol 2009, 21:1153-1160.
14. Terry M., Neugut A., Bostick R., et al. Reliability in the classification of advanced colorectal adenomas. Cancer Epidemiol Biomarkers Prev 2002, 11:660-663.
15. Costantini M., Sciallero S., Giannini A., for the SMAC workgroup, et al. Interobserver agreement in the histologic diagnosis of colorectal polyps: the experience of the multicenter adenoma colorectal study (SMAC). J Clin Epidemiol 2003, 56:209-214.
16. Komuta K., Batts J., Jessurun D. Interobserver variability in the pathological assessment of malignant colorectal polyps. Br J Surg 2004, 91:1479-1484.
17. Foss FA, Milkins S, McGregor AH. Interobserver variability in the histological assessment of colorectal polyps detected through the UK Bowel Cancer Screening Programme (submitted for publication).
18. Heitman S.J., Ronksley P.E., Hilsden R.J. Prevalence of adenomas and colorectal cancer in average risk individuals: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 2009, 7:1272-1278.
19. Strul H., Kariv R., Leshro M., et al. The prevalence rate and anatomic location of colorectal adenoma and cancer detected by colonoscopy in average risk individuals aged 40-80 years. Am J Gastroenterol 2006, 101:255-262.
20. Fearon E.R., Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990, 61:759-767.
21. Iino H., Fukayama M., Maeda Y., et al. Molecular genetics for clinical management of colorectal cancer. 17 p, 18q and 22q loss of heterozygosity and decreased DCC expression are correlated with metastatic potential. Cancer 1994, 73:1324-1331.
22. Reporting lesions in the NHS Bowel Cancer Screening Programme Guidelines from the Bowel Cancer Screening Programme Pathology Group September, 2007, NHS BCSP Publication No 1, NHS Cancer Screening Programmes.
23. Hunter J., Harmston C., Hughes P., et al. What is the nature of polyps detected by the NHS bowel cancer screening pilots?. Colorectal Dis 2011, 13:538-541.
24. http://www.virtualpathology.leeds.ac.uk.
25. Lee T., Pascall G., Wood T., et al. Colonic polyps are different in the bowel cancer screening programme population compared with the symptomatic population. Colorectal Dis 2009, 11:1462.
26. Pascall G., Wood T., Westwood C. Colonic polyps are different in the screening population as compared to the symptomatic population: results from the North East endoscopy group and bowel cancer screening programme, UK. Gut 2009, 58(S1):A121.
27. Harrow P., Nayagam N., Stafford K., et al. A comparison of incidence of colorectal cancer and polyps in bowel cancer screening programme patients with symptomatic patients referred under 2 week wait in a demographically matched population. Gastroenterology 2011, 60:A114.
28. Konishi F., Morson M.C. Pathology of colorectal adenomas: a colonoscopic survey. J Clin Pathol 1982, 35:830-841.
29. Ekelund G., Lindstrom C. Histopathological analysis of benign polyps in patients with carcinoma of the colon and rectum. Gut 1974, 15:654-663.
30. Spring K.J., Zahao Z.Z., Karamatic R., et al. High prevalence of sessile serrated adeonmas with BRAF mutations: a prospective study of patients undergoing colonoscopy. Gastroenterology 2006, 131:1400-1407.
31. Higuchi T., Sugihara K., Jass J.R. Demographic and pathological characteristics of serrated polyps of colorectum. Histopathology 2005, 47:32-40.
32. Makinen M.J. Colorectal serrated adenocarcinoma. Histopathology 2007, 50:131-150.
33. Baretton G.B. Serrated pathway of colorectal carcinogenesis. Pathologe 2010, 31:9-15.
34. O'Brien M.J., Yang S., Mack C., et al. Comparison of microsatellite instability, CPG island methylation phenotype, BRAF and Dras status in serrated polyps in traditional adenomas indicate separate pathways to distinct colorectal carcinoma endpoint. Am J Surg Pathol 2006, 30:1491-1501.
35. Yamamoto T., Konishi K., Yamochi T., et al. No major tumorigenic wall per beta-catenin and serrated as opposed to conventional colorectal adenomas. Br J Cancer 2003, 89:152-157.
36. O'Brien M.J. Hyperplastic and serrated polyps of the colorectum. Gastroenterol Clin North Am 2007, 36:947-968.
37. Makinen M.J., George S.M., Jernvall P., et al. Colorectal carcinoma associated with serrated adenoma - prevalence, histological features, and prognosis. J Pathol 2001, 193:286-294.
38. Watanabe H., Suda T. Precancerous lesions of the colon and rectum. Gan To Kagaku Ryoho 1984, 11:1-9.
39. Schreiner M.A., Weiss D.G., Lieberman D.A. Proximal and large hyperplastic and nondysplastic serrated polyps detected by colonoscopy are associated with neoplasia. Gastroenterology 2010, 139:1497-1502.
40. Soetikno R.M., Kaltenbach T., Rouse R.V., et al. Prevalence of nonpolypoid (flat and depressed) colorectal neoplasms in asymptomatic and symptomatic adults. JAMA 2008, 299:1027-1035.
41. Ishii T., Notohara K., Umapathy A., et al. Tubular adenomas with minor villous changes show molecular features characteristic of tubulovillous adenomas. Am J Surg Pathol 2011, 35:212-220.
42. Pickhardt P.J., Kim D.H. Colorectal cancer screening with CT colonography: key concepts regarding polyp prevalence, size, histology, morphology and natural history. AJR Am J Roentgenol 2009, 193:40-46.
43. Lieberman D., Moravec M., Holub J., et al. Polyp size and advancing histology in patients undergoing colonscopy screening: implications for CT colonography. Gastroenterology 2008, 135:1100-1105.
44. Bretagne J.-R., Manfredi S., Piette C., et al. Yield of high-grade dysplasia based on polyp size detected at colonoscopy: A series of 2295 examinations following a positive fecal occult blood test in a population-based study. Dis Colon Rectum 2010, 53:339-345.
45. Hassan C., Pickhardt P.J., Kim D.H., et al. Systematic review: distribution of advanced neoplasia according to polyp size at screening colonoscopy. Aliment Pharmacol Ther 2010, 31:210-217.
46. Loeve F., Boer R., Zauber A.G., et al. National polyp study data: evidence for regression of adenomas. Int J Cancer 2004, 111:633-639.
47. Quirke P., Risio M., Lambert R., et al. Quality assurance in pathology in colorectal cancer screening and diagnosis - European recommendations. Virchows Arch 2011, 458:1-19.
48. World health organization international histological classification of tumours. Pathology and genetics of tumours in the digestive system. Carcinoma of the colon and rectum 2000, 105-119. IARC, Lyon. S.R. Hamilton, L.A. Aaltonen (Eds.).
49. Haggitt R.C., Glotzbach R.E., Soffer E.E., et al. Prognostic factors in colorectal carcinomas arising in adenomas: implications for lesions removed by endoscopic polypectomy. Gastroenterology 1985, 89:328-336.
50. Kikuchi R., Takano M., Takagi K., et al. Management of early invasive colorectal cancer. Risk of recurrence and clinical guidelines. Dis Colon Rectum 1995, 38:1286-1295.
51. Wong N.A., Hunt L.P., Novelli M.R., et al. Observer agreement in the diagnosis of serrated polyps of the large bowel. Histopathology 2009, 55:63-66.
52. Farris A.B., Misdraji J., Srivastava A., et al. Sessile serrated adenoma: challenging discrimination from other serrated colonic polyps. Am J Surg Pathol 2008, 32:30-35.
53. Hetzel J.T., Huang C.S., Coukos J.A., et al. Variation in the detection of serrated polyps in an average risk colorectal cancer screening cohort. Am J Gastroent 2010, 105:2656-2664.
54. van Putten P.G., Lieke H., van Dekken H., et al. Inter-observer variation in the histological diagnosis of polyps in colorectal cancer screening. Histopathology 2011, 58:974-981.
55. Rex D.K., Hewett D.G., Snover D.C. Detection targets for colonoscopy: from variable detection to validation. Am J Gastroenterol 2010, 105:2665-2669.